In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active Compounds

Curcumin and artemisinin are commonly used in traditional East Asian medicine. In this study, we investigated the inhibitory effects of these active compounds on xanthine oxidase (XO) using allopurinol as a control. XO was purified from the serum of arthritis patients through ammonium sulfate precip...

Full description

Bibliographic Details
Main Authors: Waseem Yousif M. AL-dulaimy, Asmaa A. Hussein, Mohammed Asaad Mahdi, Mohammed Kadhom
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/13/5124
_version_ 1797591132631203840
author Waseem Yousif M. AL-dulaimy
Asmaa A. Hussein
Mohammed Asaad Mahdi
Mohammed Kadhom
author_facet Waseem Yousif M. AL-dulaimy
Asmaa A. Hussein
Mohammed Asaad Mahdi
Mohammed Kadhom
author_sort Waseem Yousif M. AL-dulaimy
collection DOAJ
description Curcumin and artemisinin are commonly used in traditional East Asian medicine. In this study, we investigated the inhibitory effects of these active compounds on xanthine oxidase (XO) using allopurinol as a control. XO was purified from the serum of arthritis patients through ammonium sulfate precipitation (65%) and ion exchange chromatography on diethylaminoethyl (DEAE)-cellulose. The specific activity of the purified enzyme was 32.5 U/mg protein, resulting in a 7-fold purification with a yield of 66.8%. Molecular docking analysis revealed that curcumin had the strongest interaction energy with XO, with a binding energy of −9.28 kcal/mol. The amino acid residues Thr1077, Gln762, Phe914, Ala1078, Val1011, Glu1194, and Ala1079 were located closer to the binding site of curcumin than artemisinin, which had a binding energy of −7.2 kcal/mol. In vitro inhibition assays were performed using nanocurcumin and artemisinin at concentrations of 5, 10, 15, 20, and 25 µg/mL. Curcumin inhibited enzyme activity by 67–91%, while artemisinin had a lower inhibition ratio, which ranged from 40–70% compared to allopurinol as a control.
first_indexed 2024-03-11T01:34:06Z
format Article
id doaj.art-552a992bdee9443693b0871c07f12ed5
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T01:34:06Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-552a992bdee9443693b0871c07f12ed52023-11-18T17:08:31ZengMDPI AGMolecules1420-30492023-06-012813512410.3390/molecules28135124In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active CompoundsWaseem Yousif M. AL-dulaimy0Asmaa A. Hussein1Mohammed Asaad Mahdi2Mohammed Kadhom3Department of Chemistry, College of Science, University of Diyala, Baquba 32001, IraqDepartment of Molecular and Medical Biotechnology, College of Biotechnology, Al-Nahrain University, Jadriya, Baghdad 64074, IraqDepartment of Chemistry, College of Science, University of Diyala, Baquba 32001, IraqDepartment of Environmental Science, College of Energy and Environmental Science, Al-Karkh University of Science, Baghdad 10081, IraqCurcumin and artemisinin are commonly used in traditional East Asian medicine. In this study, we investigated the inhibitory effects of these active compounds on xanthine oxidase (XO) using allopurinol as a control. XO was purified from the serum of arthritis patients through ammonium sulfate precipitation (65%) and ion exchange chromatography on diethylaminoethyl (DEAE)-cellulose. The specific activity of the purified enzyme was 32.5 U/mg protein, resulting in a 7-fold purification with a yield of 66.8%. Molecular docking analysis revealed that curcumin had the strongest interaction energy with XO, with a binding energy of −9.28 kcal/mol. The amino acid residues Thr1077, Gln762, Phe914, Ala1078, Val1011, Glu1194, and Ala1079 were located closer to the binding site of curcumin than artemisinin, which had a binding energy of −7.2 kcal/mol. In vitro inhibition assays were performed using nanocurcumin and artemisinin at concentrations of 5, 10, 15, 20, and 25 µg/mL. Curcumin inhibited enzyme activity by 67–91%, while artemisinin had a lower inhibition ratio, which ranged from 40–70% compared to allopurinol as a control.https://www.mdpi.com/1420-3049/28/13/5124xanthine oxidasecurcuminartemisininmolecular dockinginhibition
spellingShingle Waseem Yousif M. AL-dulaimy
Asmaa A. Hussein
Mohammed Asaad Mahdi
Mohammed Kadhom
In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active Compounds
Molecules
xanthine oxidase
curcumin
artemisinin
molecular docking
inhibition
title In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active Compounds
title_full In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active Compounds
title_fullStr In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active Compounds
title_full_unstemmed In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active Compounds
title_short In Vitro Inhibition of Xanthine Oxidase Purified from Arthritis Serum Patients by Nanocurcumin and Artemisinin Active Compounds
title_sort in vitro inhibition of xanthine oxidase purified from arthritis serum patients by nanocurcumin and artemisinin active compounds
topic xanthine oxidase
curcumin
artemisinin
molecular docking
inhibition
url https://www.mdpi.com/1420-3049/28/13/5124
work_keys_str_mv AT waseemyousifmaldulaimy invitroinhibitionofxanthineoxidasepurifiedfromarthritisserumpatientsbynanocurcuminandartemisininactivecompounds
AT asmaaahussein invitroinhibitionofxanthineoxidasepurifiedfromarthritisserumpatientsbynanocurcuminandartemisininactivecompounds
AT mohammedasaadmahdi invitroinhibitionofxanthineoxidasepurifiedfromarthritisserumpatientsbynanocurcuminandartemisininactivecompounds
AT mohammedkadhom invitroinhibitionofxanthineoxidasepurifiedfromarthritisserumpatientsbynanocurcuminandartemisininactivecompounds